DEAL Author Webinar on License Choice - DEAL Konsortium

"Choosing the right Creative Commons (CC) licence when publishing your research is crucial. The DEAL Consortium strongly advocates for the Creative Commons license type CC BY, as emphasized in our recent campaign.

To reinforce this recommendation and to give authors a deeper insight into the licence choice and its wider implications, we are pleased to invite scientific authors in Germany who publish under the DEAL agreements to an exclusive webinar.

What you will learn:

>> Why CC BY is in most cases the best choice for research publications and why other licence types such as "non-commercial" have limitations

>> How to navigate the DEAL publishing workflows to select your preferred licence

>> Insights into the terms and conditions of the "licence to publish" agreement based on your chosen licence

Bring your questions!..."